Glial fibrillary acidic protein levels pinpoint future dementia risk a decade in advance

Researchers identify GFAP as a potent biomarker for predicting dementia risk over a decade before clinical diagnosis, underscoring its potential for early screening and intervention in asymptomatic individuals.

How the world’s biggest pharma and biotech companies paid their typical worker in 2023

Among the biopharma industry’s biggest employers, California’s Gilead Sciences had the highest median salary for its workforce, an Endpoints News analysis found. Endpoints tallied 2023

July 11, 2024

Merck KGaA’s expanded AI deal; Ascletis has new biomarker data for its PD-L1; Deka closes $20M round

Merck KGaA continues AI-powered deal streak: Merck KGaA has expanded its collaboration with Israeli company Quris-AI, with an eye to identifying liver toxicity risks in

September 30, 2023

C-106 by Vicore Pharma for Idiopathic Pulmonary Fibrosis: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.